Adicet Bio, Inc. — Director's Dealing 2024

Jun 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2024-06-05

Reporting Person: Aftab Blake (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-05	Stock Option (Right to Buy)	$2.53	A	336911	Acquired	2034-01-25	Common Stock (336911)	Direct

Footnotes

F1: 1/48th of the shares shall vest in forty-eight (48) equal monthly installaments following January 26, 2024, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.